vs
艾伯维（ARGX）与标普全球（VG）财务数据对比。点击上方公司名可切换其他公司
标普全球的季度营收约是艾伯维的1.8倍（$4.4B vs $2.5B），艾伯维净利率更高（35.5% vs 26.8%，领先8.7%），标普全球同比增速更快（191.7% vs 83.2%），艾伯维自由现金流更多（$322.4M vs $-1.5B）
艾伯维是总部位于美国伊利诺伊州北芝加哥的制药企业，研发生产的药物覆盖多种疾病治疗领域，可满足多元临床需求，致力于为全球不同病症的患者提供可靠的治疗方案选择。
标普全球是总部位于美国纽约曼哈顿的上市企业，核心业务涵盖金融信息与数据分析、能源及大宗商品情报服务，旗下拥有标普全球评级、标普全球能源、标普全球市场财智、印度信用评级机构CRISIL等子品牌，同时是标普道琼斯指数合资公司的控股股东。
ARGX vs VG — 直观对比
营收规模更大
VG
是对方的1.8倍
$2.5B
营收增速更快
VG
高出108.5%
83.2%
净利率更高
ARGX
高出8.7%
26.8%
自由现金流更多
ARGX
多$1.8B
$-1.5B
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.5B | $4.4B |
| 净利润 | $877.2M | $1.2B |
| 毛利率 | 89.5% | — |
| 营业利润率 | 28.9% | 38.7% |
| 净利率 | 35.5% | 26.8% |
| 营收同比 | 83.2% | 191.7% |
| 净利润同比 | 1.3% | 20.3% |
| 每股收益（稀释后） | $13.25 | $0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARGXVG
| Q4 25 | $2.5B | $4.4B | ||
| Q3 25 | — | $3.3B | ||
| Q2 25 | $1.8B | $3.1B | ||
| Q1 25 | — | $2.9B | ||
| Q4 24 | $1.4B | $1.5B | ||
| Q3 24 | — | $926.0M | ||
| Q2 24 | $901.9M | $1.1B | ||
| Q1 24 | — | $1.4B |
净利润ARGXVG
| Q4 25 | $877.2M | $1.2B | ||
| Q3 25 | — | $550.0M | ||
| Q2 25 | $414.8M | $475.0M | ||
| Q1 25 | — | $517.0M | ||
| Q4 24 | $865.6M | $990.0M | ||
| Q3 24 | — | $-294.0M | ||
| Q2 24 | $-32.5M | $352.0M | ||
| Q1 24 | — | $698.0M |
毛利率ARGXVG
| Q4 25 | 89.5% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 89.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 90.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 89.4% | — | ||
| Q1 24 | — | — |
营业利润率ARGXVG
| Q4 25 | 28.9% | 38.7% | ||
| Q3 25 | — | 39.7% | ||
| Q2 25 | 19.2% | 33.5% | ||
| Q1 25 | — | 37.3% | ||
| Q4 24 | 8.7% | 39.0% | ||
| Q3 24 | — | 20.4% | ||
| Q2 24 | -15.4% | 32.8% | ||
| Q1 24 | — | 43.6% |
净利率ARGXVG
| Q4 25 | 35.5% | 26.8% | ||
| Q3 25 | — | 16.5% | ||
| Q2 25 | 23.4% | 15.3% | ||
| Q1 25 | — | 17.9% | ||
| Q4 24 | 64.1% | 65.0% | ||
| Q3 24 | — | -31.7% | ||
| Q2 24 | -3.6% | 31.8% | ||
| Q1 24 | — | 49.4% |
每股收益（稀释后）ARGXVG
| Q4 25 | $13.25 | $0.41 | ||
| Q3 25 | — | $0.16 | ||
| Q2 25 | $6.32 | $0.14 | ||
| Q1 25 | — | $0.15 | ||
| Q4 24 | $13.33 | $0.35 | ||
| Q3 24 | — | $-0.15 | ||
| Q2 24 | $-0.55 | $0.12 | ||
| Q1 24 | — | $0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5B | $2.4B |
| 总债务越低越好 | — | $34.2B |
| 股东权益账面价值 | $7.3B | $6.7B |
| 总资产 | $8.7B | $53.4B |
| 负债/权益比越低杠杆越低 | — | 5.07× |
8季度趋势，按日历期对齐
现金及短期投资ARGXVG
| Q4 25 | $3.5B | $2.4B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | $2.1B | $2.2B | ||
| Q1 25 | — | $3.6B | ||
| Q4 24 | $1.5B | $3.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | — | — |
总债务ARGXVG
| Q4 25 | — | $34.2B | ||
| Q3 25 | — | $32.6B | ||
| Q2 25 | — | $30.0B | ||
| Q1 25 | — | $29.3B | ||
| Q4 24 | — | $29.3B | ||
| Q3 24 | — | — | ||
| Q2 24 | $11.0M | — | ||
| Q1 24 | — | — |
股东权益ARGXVG
| Q4 25 | $7.3B | $6.7B | ||
| Q3 25 | — | $5.7B | ||
| Q2 25 | $6.1B | $5.3B | ||
| Q1 25 | — | $4.9B | ||
| Q4 24 | $5.5B | $2.9B | ||
| Q3 24 | — | — | ||
| Q2 24 | $4.3B | — | ||
| Q1 24 | — | — |
总资产ARGXVG
| Q4 25 | $8.7B | $53.4B | ||
| Q3 25 | — | $50.1B | ||
| Q2 25 | $7.2B | $46.5B | ||
| Q1 25 | — | $45.1B | ||
| Q4 24 | $6.2B | $43.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | $4.8B | — | ||
| Q1 24 | — | — |
负债/权益比ARGXVG
| Q4 25 | — | 5.07× | ||
| Q3 25 | — | 5.73× | ||
| Q2 25 | — | 5.69× | ||
| Q1 25 | — | 6.01× | ||
| Q4 24 | — | 10.11× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $323.3M | $2.1B |
| 自由现金流经营现金流 - 资本支出 | $322.4M | $-1.5B |
| 自由现金流率自由现金流/营收 | 13.0% | -34.1% |
| 资本支出强度资本支出/营收 | 0.0% | 81.6% |
| 现金转化率经营现金流/净利润 | 0.37× | 1.77× |
| 过去12个月自由现金流最近4个季度 | $594.5M | $-6.8B |
8季度趋势，按日历期对齐
经营现金流ARGXVG
| Q4 25 | $323.3M | $2.1B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | $361.8M | $1.5B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $41.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-124.7M | — | ||
| Q1 24 | — | $638.0M |
自由现金流ARGXVG
| Q4 25 | $322.4M | $-1.5B | ||
| Q3 25 | — | $-1.4B | ||
| Q2 25 | $356.6M | $-1.5B | ||
| Q1 25 | — | $-2.4B | ||
| Q4 24 | $40.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-125.5M | — | ||
| Q1 24 | — | $-2.4B |
自由现金流率ARGXVG
| Q4 25 | 13.0% | -34.1% | ||
| Q3 25 | — | -42.4% | ||
| Q2 25 | 20.1% | -49.1% | ||
| Q1 25 | — | -81.3% | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -13.9% | — | ||
| Q1 24 | — | -167.3% |
资本支出强度ARGXVG
| Q4 25 | 0.0% | 81.6% | ||
| Q3 25 | — | 98.9% | ||
| Q2 25 | 0.3% | 96.1% | ||
| Q1 25 | — | 119.8% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | — | 212.4% |
现金转化率ARGXVG
| Q4 25 | 0.37× | 1.77× | ||
| Q3 25 | — | 3.42× | ||
| Q2 25 | 0.87× | 3.07× | ||
| Q1 25 | — | 2.15× | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.91× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARGX
暂无分部数据
VG
| Plaquemines Project Segment | $3.4B | 76% |
| Calcasieu Project Segment | $841.0M | 19% |
| Other | $208.0M | 5% |
